Cargando…
Biomolecular Network-Based Synergistic Drug Combination Discovery
Drug combination is a powerful and promising approach for complex disease therapy such as cancer and cardiovascular disease. However, the number of synergistic drug combinations approved by the Food and Drug Administration is very small. To bridge the gap between urgent need and low yield, researche...
Autores principales: | Li, Xiangyi, Qin, Guangrong, Yang, Qingmin, Chen, Lanming, Xie, Lu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5116515/ https://www.ncbi.nlm.nih.gov/pubmed/27891522 http://dx.doi.org/10.1155/2016/8518945 |
Ejemplares similares
-
Biomolecular network-based synergistic drug combination discovery: a combination of paeoniflorin and liquiritin alleviates neuropathic pain by inhibiting neuroinflammation via suppressing the chemokine signaling pathway
por: Guo, Qiuyan, et al.
Publicado: (2020) -
Biomolecular NMR: a chaperone to drug discovery
por: Betz, Marco, et al.
Publicado: (2006) -
Biomolecular network motif counting and discovery by color coding
por: Alon, Noga, et al.
Publicado: (2008) -
Discovery of a kernel for controlling biomolecular regulatory networks
por: Kim, Junil, et al.
Publicado: (2013) -
Specificity quantification of biomolecular recognition and its implication for drug discovery
por: Yan, Zhiqiang, et al.
Publicado: (2012)